Optics
← Today's headlines

3 sources checked · 2 source groups included · 1h ago

Still Watching

Grail’s cancer-screen test wins tepid support from drug advisory panel

Scientific American and Financial Times - Companies describe the same event in different terms.

2 Left1 Center0 Right
Still watching. Optics is waiting for a cleaner match before calling the split.

STILL WATCHING

As of September 24, 2026 at 12:35 AM, this is how Optics News reads the wording differences in this story.

What happened FDA committee expressed concerns about effectiveness and overall benefits for a product that failed a UK study earlier this year.
The headline split The left frames it as "FDA advisory panel endorses controversial cancer blood test". The center frames it as "Grail’s cancer-screen test wins tepid support from drug advisory panel".
Match confidence Medium confidence. 3 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium

3 sources across 2 bias buckets agree on the event.

Framing confidenceModerate

74/99 — meaningful wording shift across the spectrum.

WHAT EACH SIDE EMPHASIZED

Left / center-leftFDA advisory panel endorses controversial cancer blood test

The Seattle Times · Center-left · News report

CenterGrail’s cancer-screen test wins tepid support from drug advisory panel

Financial Times - Companies · Center · News report

Right / center-rightNo matching source in this bucket yet.

Optics keeps watching for pickup.

SEE THE HEADLINES

Center-leftHigh
The Seattle TimesNews report · Sep 24, 12:35 AM

FDA advisory panel endorses controversial cancer blood test

The panelists expressed reservations about the evidence supporting Grail’s Galleri test, which is designed to detect cancers early.

Open source
CenterHigh
Financial Times - CompaniesNews report · Sep 23, 11:13 PM

Grail’s cancer-screen test wins tepid support from drug advisory panel

FDA committee expressed concerns about effectiveness and overall benefits for a product that failed a UK study earlier this year

Open source
Center-leftHigh
Scientific AmericanNews report · Sep 23, 11:08 PM

Blood test for multiple cancers clears crucial hurdle on track to FDA approval

If approved, the test could help catch cancers early—but more research is still needed, experts say

Open source
Details74/99 Wording Gap · Medium confidence · 3 sources
74/99 Wording GapMedium confidence3 sources · 2 bias bucketsLive match · 3 sources · 2 buckets · comparable news formatFormats: News report

SOURCE MAP CHANGES

Sep 23, 11:08 PM: Scientific American joined the source map.

Sep 23, 11:13 PM: Financial Times - Companies joined the source map.

Sep 24, 12:35 AM: The Seattle Times joined the source map.

Now: Wording Gap is 74/99 and story health is live match · 3 sources · 2 buckets · comparable news format.